Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial.
暂无分享，去创建一个
G. Garcia-Manero | Xuelin Huang | K. Patel | T. Kadia | F. Ravandi | E. Jabbour | N. Jain | N. Short | A. Ferrajoli | Y. Alvarado | H. Kantarjian | R. Garris | P. Thompson | M. Yilmaz | M. Konopleva | W. Macaron | Rebecca E. Garris